GABAergic Hub Stabilization Through α5-Subunit Inverse Agonists

Mechanistic description

Mechanism / pathway

GABAergic Hub Stabilization
→
connectomics

Evidence for (5)

Inhibitory deficits precede and drive network hyperactivity in AD models

PMID:20167333
Activity-dependent degeneration explains hub vulnerability - highly active neurons accumulate more pathology

PMID:22817841
GABA-A α5 is enriched in hippocampus and cortex, regions rich in hub neurons

PMID:25834165
α5 inverse agonists reduce excitotoxicity without cognitive impairment in preclinical models

PMID:26226646
Hub neurons show elevated oxidative stress and metabolic activity

PMID:20644199

Evidence against (5)

RG1662 (α5 inverse agonist) failed in Down syndrome clinical trials - no cognitive benefit

PMID:NCT02098369
Inverted U-shaped relationship: both excessive activity AND suppression alter amyloid dynamics

PMID:25239499
Hyperexcitability in AD may be compensatory rather than pathogenic

PMID:25239499
Field abandoned α5 inverse agonists - Roche discontinued RG1662

PMID:26226646
Cognitive stimulation (increasing hub activity) is protective against AD

PMID:25239499

Evidence matrix

5 supporting 5 contradicting

50% supporting

Supporting

Inhibitory deficits precede and drive network hyperactivity in AD models PMID:20167333
Activity-dependent degeneration explains hub vulnerability - highly active neurons accumulate more pathology PMID:22817841
GABA-A α5 is enriched in hippocampus and cortex, regions rich in hub neurons PMID:25834165
α5 inverse agonists reduce excitotoxicity without cognitive impairment in preclinical models PMID:26226646
Hub neurons show elevated oxidative stress and metabolic activity PMID:20644199

Contradicting

RG1662 (α5 inverse agonist) failed in Down syndrome clinical trials - no cognitive benefit PMID:NCT02098369
Inverted U-shaped relationship: both excessive activity AND suppression alter amyloid dynamics PMID:25239499
Hyperexcitability in AD may be compensatory rather than pathogenic PMID:25239499
Field abandoned α5 inverse agonists - Roche discontinued RG1662 PMID:26226646
Cognitive stimulation (increasing hub activity) is protective against AD PMID:25239499

Cite this hypothesis

Citation

etl-backfill (2026). GABAergic Hub Stabilization Through α5-Subunit Inverse Agonists. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-ae112108

BibTeX

@misc{scidex_hypothesis_hae11210,
  title        = {GABAergic Hub Stabilization Through α5-Subunit Inverse Agonists},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-ae112108},
  note         = {SciDEX artifact hypothesis:h-ae112108}
}